Download presentation
Presentation is loading. Please wait.
1
Volume 61, Issue 4, Pages 1462-1468 (April 2002)
Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension1 Christian Delles, Johannes Jacobi, Stefan John, Ingrid Fleischmann, Roland E. Schmieder Kidney International Volume 61, Issue 4, Pages (April 2002) DOI: /j x Copyright © 2002 International Society of Nephrology Terms and Conditions
2
Figure 1 Contribution of the renal vascular nitric oxide system to the effects of treatment on renal plasma flow. The response of renal plasma flow (RPF) on inhibition of nitric oxide with NG-monomethyl-L-arginine (L-NMMA; that is, the change in RPF) in the respective study phases is shown on the x-axis. Changes of basal RPF with enalapril, eprosartan, and combination therapy are shown on the y-axis of panels A (r = -0.44, P = NS), B (r = -0.86, P !0.001), and C (r = -0.70, P = 0.002), respectively. Kidney International , DOI: ( /j x) Copyright © 2002 International Society of Nephrology Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.